BetterLife Pharma (BETRF) Short Interest Ratio & Short Volume

Short interest is the volume of BetterLife Pharma shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 2,400 shares of BETRF short. Learn More on BetterLife Pharma's current short interest.

BetterLife Pharma saw a decrease in short interest in the month of April. As of April 30th, there was short interest totaling 2,400 shares, a decrease of 83.8% from the previous total of 14,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to BetterLife Pharma: NuCana plc (1.21%), Addex Therapeutics Ltd (1.85%), Alterity Therapeutics Limited (1.03%), Molecular Templates, Inc. (4.68%), Chemomab Therapeutics Ltd. (0.98%), Aeterna Zentaris Inc. (0.34%), Galera Therapeutics, Inc. (7.34%), Guardion Health Sciences, Inc. (14.33%), Moleculin Biotech, Inc. (1.45%), MIRA Pharmaceuticals, Inc. (0.42%),

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

Short selling BETRF is an investing strategy that aims to generate trading profit from BetterLife Pharma as its price is falling. BETRF shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for BetterLife Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BETRF, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BETRF, twice per month. The most recent reporting period available is April, 30 2024.